What is FMODD?
The FMO Drug Design Consortium (FMODD) is a non-profit organization promoting application of the fragment molecular orbital (FMO) method for drug design. In FMODD, the industry and academia are working together using High Performance Computing Infrastructure (HPCI), such as Fugaku computer, to advance the technology based on FMO and spread FMO as a fundamental method for in silico drug design.
The “FMO” part implies that the FMO method is analyzing a compound at the level of its functional groups, while the “DD” part represents a capsule drug on the market. This logo thus expresses our hope to connect FMO with practical drug design.
Yoshio Okiyama, National Institute of Health Sciences [Download logos]